Capricorn Fund Managers’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.21M Buy
+63,900
New +$4.61M 0.41% 72

Other funds holding PTCT

Capricorn Fund Managers's PTCT Position: Q2 2026 in Review

Capricorn Fund Managers opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 63,900 shares worth $5.21M. The stake represents 0.41% of the portfolio and ranks #72 among its holdings.

69 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Capricorn Fund Managers held 63,900 shares of PTC Therapeutics worth $5.21M as of Q2 2026.
  • PTC Therapeutics was a new Capricorn Fund Managers position in Q2 2026.
  • PTC Therapeutics made up 0.41% of Capricorn Fund Managers's portfolio in Q2 2026, its #72 holding.
  • 69 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.